PROLOR Biotech

Developing longer-acting versions of therapeutic proteins for various diseases.

Health Tech & Life Sciences
Acquired by OPKO Health
Acquired Ness Ziona, Israel Founded 1991
Website ↗
Last updated 2026-07-20
Total raised
Stage
Acquired
Founded
1991
Headcount
31
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

PROLOR Biotech was an Israeli clinical-stage biopharmaceutical company focused on developing longer-acting proprietary versions of already approved therapeutic proteins using its patented CTP (carboxyl-terminal peptide) technology. The company's pipeline included treatments for growth hormone deficiency, hemophilia, obesity, and diabetes. PROLOR Biotech was acquired by OPKO Health in 2013.

Funding history · 1 round · — total

2010-02
Follow-on PO Undisclosed

Q&A

What is PROLOR Biotech's primary business?
PROLOR Biotech develops proprietary, longer-acting versions of existing therapeutic proteins and peptide drugs, aiming to reduce administration frequency for treatments like human growth hormone.
When was PROLOR Biotech founded?
PROLOR Biotech was founded in January 2005.
What is the current status of PROLOR Biotech?
PROLOR Biotech was acquired by OPKO Health in August 2013 and is currently inactive.
Which company acquired PROLOR Biotech?
PROLOR Biotech was acquired by OPKO Health in August 2013.
What are the main product areas PROLOR Biotech focused on?
PROLOR Biotech's primary products were designed to treat growth hormone deficiency, hemophilia, and type 2 diabetes.
In which sector does PROLOR Biotech operate?
PROLOR Biotech operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.
How many employees did PROLOR Biotech have at the time of its acquisition?
PROLOR Biotech had an employee count in the 11-50 range.
Where is PROLOR Biotech's headquarters located?
PROLOR Biotech's headquarters is located in Ness Ziona, Center District, Israel.

Team · 2

Shai Novik
Founder · Founder
Fuad Fares
Founder · Chief Scientific Officer and Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

proteinstherapeuticsbiopharmaceuticalobesitybiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteprolor-biotech.com

Identifiers & details

Legal namePROLOR Biotech, Inc.
Founded1991
Employees (exact)31
Status reasonAcquired (Inactive) by OPKO Health on Aug 2013 - closed due to acquisition

Acquisitions & public offerings

Acquired by OPKO Health 2013-08 $480.0M

Radar intelligence

Patents

EPO18